Log in to save to my catalogue

PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling

PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3291810

PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling

About this item

Full title

PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2012-07, Vol.31 (29), p.3397-3408

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Activating mutations in the RAS family or
BRAF
frequently occur in many types of human cancers but are rarely detected in breast tumors. However, activation of the RAS–RAF–MEK–ERK MAPK pathway is commonly observed in human breast cancers, suggesting that other genetic alterations lead to activation of this signaling pathway. To identify breas...

Alternative Titles

Full title

PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3291810

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3291810

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/onc.2011.515

How to access this item